Harms Henrik, Klöckner Anna, Schrör Jan, Josten Michaele, Kehraus Stefan, Crüsemann Max, Hanke Wiebke, Schneider Tanja, Schäberle Till F, König Gabriele M
Institute for Pharmaceutical Biology, University of Bonn, Germany.
German Center for Infection Research (DZIF) Partner Site Cologne/Bonn, Germany.
Planta Med. 2018 Dec;84(18):1363-1371. doi: 10.1055/a-0653-7451. Epub 2018 Jul 10.
has been reported as a seaweed-associated or marine-derived species with largely unknown secondary metabolites. The combination of bioinformatic analysis and MS- and bioactivity guided separation led to the isolation of a new antibiotically active dialkylresorcin from the marine bacterium . The antibiotic profile of the new dialkylresorcin zobelliphol (1: ) was investigated and compared with related and naturally occurring dialkyresorcins (i.e., stemphol (2: ) and 4-butyl-3,5-dihydroxybenzoic acid (3: )) from the marine-derived fungus . Bacterial reporter strain assays provided insights into the mode of action of this antibiotic compound class. We identified an interference with bacterial DNA biosynthesis for the dialkylresorcin derivative 1: . In addition, the putative biosynthetic gene cluster corresponding to production of 1: was identified and a biosynthetic hypothesis was deduced.
据报道,它是一种与海藻相关或源自海洋的物种,其次生代谢产物大多未知。通过生物信息学分析以及质谱和生物活性导向分离相结合的方法,从海洋细菌中分离出一种新的具有抗生素活性的二烷基间苯二酚。对新的二烷基间苯二酚zobelliphol(1: )的抗生素谱进行了研究,并与源自海洋的真菌中的相关天然存在的二烷基间苯二酚(即stemphol(2: )和4-丁基-3,5-二羟基苯甲酸(3: ))进行了比较。细菌报告菌株分析为这类抗生素化合物的作用方式提供了见解。我们确定二烷基间苯二酚衍生物1: 会干扰细菌DNA生物合成。此外,还鉴定了与1: 的产生相对应的假定生物合成基因簇,并推导了生物合成假说。